ProShare Advisors’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,531
Closed -$291K 2138
2024
Q2
$291K Sell
8,531
-1,828
-18% -$54.2K ﹤0.01% 1308
2024
Q1
$365K Buy
10,359
+1,099
+12% +$36.8K ﹤0.01% 1292
2023
Q4
$267K Buy
+9,260
New +$221K ﹤0.01% 1462
2023
Q3
Sell
-6,921
Closed -$397K 1874
2023
Q2
$397K Buy
6,921
+1,151
+20% +$60.1K ﹤0.01% 1090
2023
Q1
$217K Buy
+5,770
New +$213K ﹤0.01% 1403
2022
Q2
Sell
-7,801
Closed -$313K 2192
2022
Q1
$313K Sell
7,801
-2,030
-21% -$85K ﹤0.01% 1604
2021
Q4
$466K Buy
+9,831
New +$527K ﹤0.01% 1505
2021
Q3
Sell
-5,379
Closed -$309K 2315
2021
Q2
$309K Buy
5,379
+1,658
+45% +$91.2K ﹤0.01% 1877
2021
Q1
$235K Buy
+3,721
New +$171K ﹤0.01% 1942

Other funds holding MORF

ProShare Advisors's MORF Position: Q3 2024 in Review

ProShare Advisors sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 8,531 shares — an estimated $291K sold.

ProShare Advisors first reported a position in MORF in Q1 2021 and held it in 9 quarters. The position peaked at $466K in Q4 2021. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

  • ProShare Advisors reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • ProShare Advisors sold 8,531 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $291K.
  • ProShare Advisors first reported a position in Morphic Holding, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • ProShare Advisors's Morphic Holding, Inc. Common Stock position peaked at $466K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.